Elevance Health (ELV) Accumulated Depreciation & Amortization (2009 - 2025)

Elevance Health (ELV) has 17 years of Accumulated Depreciation & Amortization data on file, last reported at $4.1 billion in Q4 2025.

• Quarterly Accumulated Depreciation & Amortization rose 10.31% year-over-year to $4.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.1 billion (up 10.31% YoY) and the FY2025 annual result came in at $4.1 billion, up 10.31% from the prior year.
• Accumulated Depreciation & Amortization rose to $4.1 billion in Q4 2025 per ELV's latest filing, from $3.7 billion in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $4.3 billion in Q4 2021 and bottomed at $2.8 billion in Q4 2022.
• The 5-year median for Accumulated Depreciation & Amortization is $3.7 billion (2024), against an average of $3.7 billion.
• The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization slumped 35.41%; it then climbed 26.44% in 2023.
• Tracing ELV's Accumulated Depreciation & Amortization over 5 years: stood at $4.3 billion in 2021, then sank by 35.41% to $2.8 billion in 2022, then rose by 26.44% to $3.5 billion in 2023, then climbed by 3.75% to $3.7 billion in 2024, then climbed by 10.31% to $4.1 billion in 2025.
• Per Business Quant, the three latest ELV Accumulated Depreciation & Amortization figures stand at $4.1 billion (Q4 2025), $3.7 billion (Q4 2024), and $3.5 billion (Q4 2023).

Peer Comparison